Enliven Therapeutics, Inc. (ELVN) SEC filings

ELVN SEC filings moved a median of -0.85% by the close. ELVN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ELVN overview →

42 measured ELVN SEC filing events.

Where these ELVN SEC filings landedvs 39 measured ELVN SEC filing reactions
ELVN SEC filingMiddle 50% · -4.15% to +1.87%Zero: 0.00%Median: -0.85%Median -0.85%-6.00%0+6.00%
Middle 50% of ELVN SEC filing reactions-4.15% to +1.87%
Median reaction (to close)-0.85%
Measured reactions39
Point-in-time · zero look-ahead

Half of the 39 ELVN SEC filing events with a measured close landed between -4.15% and +1.87%; 31% closed up.

DateHeadlineEvent5-minTo close
Form 8-K Enliven Therapeutics, For: Oct 14SEC filing · Form 8-K-0.28%-0.38%
Form 10-Q Enliven Therapeutics, For: Jun 30SEC filing · Form 10-Q+0.37%+1.57%
Form 8-K Enliven Therapeutics, For: Aug 05SEC filing · Form 8-K+0.37%+1.57%
Form 8-K Enliven Therapeutics, For: Jun 11SEC filing · Form 8-K+0.90%-7.17%
Form 8-K Enliven Therapeutics, For: Jun 11SEC filing · Form 8-K-4.51%-10.31%
Form 8-K Enliven Therapeutics, For: Jun 09SEC filing · Form 8-K+1.69%+3.61%
Form 10-Q Enliven Therapeutics, For: Mar 31SEC filing · Form 10-Q-0.23%-2.60%
Form 8-K Enliven Therapeutics, For: May 07SEC filing · Form 8-K-0.23%-2.60%
Form ARS Enliven Therapeutics, For: Dec 31SEC filing · Form ARS-0.03%-4.15%
Form DEF 14A Enliven Therapeutics, For: Jun 09SEC filing · Form DEF-0.03%-4.15%
Form DEFA14A Enliven Therapeutics,SEC filing · Form DEFA14A-0.03%-4.15%
Form PRE 14A Enliven Therapeutics, For: Jun 09SEC filing · Form PRE-0.84%+3.42%
Form 10-K Enliven Therapeutics, For: Dec 31SEC filing · Form 10-K+0.00%+4.86%
Form 8-K Enliven Therapeutics, For: Mar 03SEC filing · Form 8-K+0.00%+4.86%
Form S-8 Enliven Therapeutics,SEC filing · Form S-8+0.00%+4.86%
Form 8-K Enliven Therapeutics, For: Jan 06SEC filing · Form 8-K+1.12%+2.18%
Form S-8 Enliven Therapeutics,SEC filing · Form S-8+1.77%-5.49%
Form 8-K Enliven Therapeutics, For: Dec 09SEC filing · Form 8-K-0.85%-6.10%
Form 8-K/A Enliven Therapeutics, For: Nov 12SEC filing · Form 8-K+0.61%—
Form 10-Q Enliven Therapeutics, For: Sep 30SEC filing · Form 10-Q+0.61%—
Form 8-K Enliven Therapeutics, For: Nov 12SEC filing · Form 8-K+0.61%—
Form 10-Q Enliven Therapeutics, For: Jun 30SEC filing · Form 10-Q+1.08%-0.85%
Form 8-K Enliven Therapeutics, For: Aug 13SEC filing · Form 8-K+1.08%-0.85%
Form S-3ASR Enliven Therapeutics,SEC filing · Form S-3ASR+1.08%-0.85%
Form 8-K Enliven Therapeutics, For: Jun 24SEC filing · Form 8-K-1.57%-0.32%
Form 8-K Enliven Therapeutics, For: Jun 13SEC filing · Form 8-K-1.75%-1.24%
Form 8-K Enliven Therapeutics, For: Jun 13SEC filing · Form 8-K+8.61%+18.24%
Form S-3MEF Enliven Therapeutics,SEC filing · Form S-3MEF+8.61%+18.24%
Form 10-Q Enliven Therapeutics, For: Mar 31SEC filing · Form 10-Q-5.20%-8.33%
Form 8-K Enliven Therapeutics, For: May 14SEC filing · Form 8-K-5.20%-8.33%
Form ARS Enliven Therapeutics, For: Dec 31SEC filing · Form ARS-0.38%-0.16%
Form DEF 14A Enliven Therapeutics, For: Jun 24SEC filing · Form DEF-0.38%-0.16%
Form DEFA14A Enliven Therapeutics,SEC filing · Form DEFA14A-0.38%-0.16%
Form 10-K Enliven Therapeutics, For: Dec 31SEC filing · Form 10-K+1.42%-1.71%
Form 8-K Enliven Therapeutics, For: Mar 13SEC filing · Form 8-K+1.42%-1.71%
Form S-8 Enliven Therapeutics,SEC filing · Form S-8+1.42%-1.71%
Form 10-Q Enliven Therapeutics, For: Sep 30SEC filing · Form 10-Q-0.27%-5.53%
Form 8-K Enliven Therapeutics, For: Nov 13SEC filing · Form 8-K-0.27%-5.53%
Form 10-Q Enliven Therapeutics, For: Jun 30SEC filing · Form 10-Q-3.50%-2.85%
Form 8-K Enliven Therapeutics, For: Aug 13SEC filing · Form 8-K-3.50%-2.85%
Form S-8 Enliven Therapeutics,SEC filing · Form S-8+0.00%+3.44%
Form 8-K Enliven Therapeutics, For: Jun 18SEC filing · Form 8-K+0.00%+3.44%
That’s how ELVN usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More ELVN: earnings → · analyst actions → · ELVN overview →